Verrica Pharmaceuticals Inc. Annual Depreciation in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Verrica Pharmaceuticals Inc. quarterly/annual Depreciation history and growth rate from 2018 to 2023.
  • Verrica Pharmaceuticals Inc. Depreciation for the quarter ending September 30, 2024 was $100K, unchanged year-over-year.
  • Verrica Pharmaceuticals Inc. Depreciation for the twelve months ending September 30, 2024 was $525K.
  • Verrica Pharmaceuticals Inc. annual Depreciation for 2023 was $530K, a 16.7% increase from 2022.
  • Verrica Pharmaceuticals Inc. annual Depreciation for 2022 was $454K, a 86.1% increase from 2021.
  • Verrica Pharmaceuticals Inc. annual Depreciation for 2021 was $244K, a 467% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $530K +$76K +16.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $454K +$210K +86.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $244K +$201K +467% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-06
2020 $43K -$21.2K -33% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-02
2019 $64.2K +$43.9K +216% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-17
2018 $20.3K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.